IOVA Iovance Biotherapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$14.22
· of 52w range
· above low
· to high
$1.7652w low
$15.3052w high
Market Cap (MRQ)
$6.44B
P/E
-13.0
EPS
$-1.09
Revenue
$264M
your badges
52W Range
$2–$15
Analyst Rating
BUY
Price Target
$12
P/E
-13.0
ROE
-56.0%
Net Profit Margin
-89.1%
Your badge strip is empty — pin a metric anywhere on this page.
IOVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$14.21
Market Cap (MRQ)
$6.44B
P/E
-13.0
EPS
$-1.09
Revenue
$264M
ROE
-56.0%
Debt/Equity
0.0
52W Range
$2–$15
IOVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Sept. 26, 2013 | 1-for-100 | Reverse |
About Iovance Biotherapeutics, Inc. - Common Stock Company overview from Wikipedia
Iovance Biotherapeutics, Inc. is a biopharmaceutical company based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
## History
The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became Lion Bio Pharma, which was then rebranded to Iovance in 2017.
In 2024, the US FDA gave accelerated approval to Lifileucel, marketed under the brand name Amtagvi, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.
TIL monotherapy and TIL combination therapies are being investigated by Iovance in multiple clinical studies in multiple advanced solid tumor cancers such as NSCLC and sarcoma.
TIL therapy is manufactured at their 136,000–square-foot Cell Therapy Center, located in Philadelphia, PA, using proprietary good manufacturing practices (GMP).
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealthcare
industryBiotechnology
employees975
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$264M2016-12-31 → 2025-12-31
EPS$-1.092019-12-31 → 2025-12-31
Free Cash Flow$-336M2016-12-31 → 2025-12-31
Net margin-89.1%2023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | IOVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -13.05Y avg ≈-4.7 | ≈-4.7 | · | · | |
| P/S (TTM) | 19.85Y avg ≈589.8 | ≈589.8 | 31.8 | Undervalued | |
| P/B (MRQ) | 8.75Y avg ≈3.1 | ≈3.1 | 9.0 | Undervalued | |
| EV / EBITDA | -14.2 | · | · | · | |
| Price / FCF (TTM) | -21.75Y avg ≈-6.0 | ≈-6.0 | · | · | |
| Price / Cash Flow (TTM) | -24.45Y avg ≈-6.6 | ≈-6.6 | · | · | |
| EV / Revenue | 21.1 | · | · | · | |
| EV / FCF | -16.5 | · | · | · | |
| Price / Tangible Book (MRQ) | 13.65Y avg ≈4.2 | ≈4.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | IOVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -92.7%5Y avg ≈-13043.0% | ≈-13043.0% | -68.1% | Top tier | |
| EBITDA Margin (TTM) | -88.6%5Y avg ≈-12714.6% | ≈-12714.6% | -68.1% | Top tier | |
| Pretax Margin (TTM) | -90.4%5Y avg ≈-12671.9% | ≈-12671.9% | -68.6% | Top tier | |
| Net Profit Margin (TTM) | -89.1%5Y avg ≈-12573.5% | ≈-12573.5% | -157.9% | Top tier | |
| ROA | -42.9%5Y avg ≈-49.5% | ≈-49.5% | -22.4% | Weak | |
| ROE | -56.0%5Y avg ≈-63.4% | ≈-63.4% | -56.0% | In line | |
| ROIC | -57.4%5Y avg ≈-63.6% | ≈-63.6% | -23.2% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | IOVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | · | 0.8 | Low debt | |
| Current Ratio (MRQ) | 4.35Y avg ≈4.1 | ≈4.1 | 7.3 | Low liquidity | |
| Quick Ratio (MRQ) | 3.75Y avg ≈3.9 | ≈3.9 | 3.7 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | IOVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 60.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | IOVA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.35Y avg ≈0.2 | ≈0.2 | 0.0 | Top tier | |
| Inventory Turnover | 3.45Y avg ≈3.1 | ≈3.1 | · | · | |
| Receivables Turnover | 3.55Y avg ≈8.0 | ≈8.0 | 7.9 | Weak | |
| Revenue / Employee | ≈$270.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-11.5%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $-0.11 | $-0.13 | 14.3% |
| March 31, 2026 | May 7, 2026 | $-0.19 | $-0.15 | -24.3% |
| Dec. 31, 2025 | $-0.18 | $-0.18 | -2.8% | |
| Sept. 30, 2025 | $-0.25 | $-0.26 | 5.0% | |
| June 30, 2025 | $-0.33 | $-0.29 | -13.7% | |
| March 31, 2025 | $-0.36 | $-0.24 | -47.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $164M | $1M | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $173M | $93M | $1M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $300M | $276M | $333M | $295M | $259M | $202M | $166M | $100M | $72M | $27M | $15M | $4M | |
| SG&A Expense | $152M | $152M | $106M | $104M | $84M | $60M | $41M | $28M | $21M | $27M | $12M | $8M | |
| Operating Expenses | $667M | $559M | $462M | $399M | $343M | $262M | $207M | $128M | $93M | $54M | $28M | $12M | |
| Operating Income | $-403M | $-395M | $-461M | $-399M | $-343M | $-262M | $-207M | $-128M | $-93M | $-54M | $-28M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $-5.7K | |
| Interest Income | $10M | $20M | $13M | $3M | $451.0K | $2M | $9M | $5M | $813.0K | $745.0K | $200.0K | $6.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $200.0K | $6.0K | |
| Pretax Income | $-393M | $-375M | $-448M | $-396M | $-342M | · | · | · | · | · | · | · | |
| Income Tax | $-2M | $-3M | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| EPS (Basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| EPS (Diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| Shares (Basic) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| Shares (Diluted) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| EBITDA | $-390M | $-383M | $-449M | $-390M | $-340M | $-261M | $-206M | $-128M | $-93M | $-54M | $-28M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $116M | $115M | $232M | $78M | $67M | $14M | $82M | $145M | $107M | $34M | $45M | |
| Short-term Investments | $134M | $208M | $165M | $240M | $426M | $562M | $293M | $386M | $0 | $60M | $70M | $0 | |
| Receivables | $82M | $69M | $151.0K | · | · | · | · | · | · | · | · | · | |
| Inventory | $52M | $52M | $10M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $12M | $12M | $17M | $7M | $4M | $7M | $9M | $7M | $4M | $3M | $277.0K | $66.0K | |
| Current Assets | $443M | $457M | $308M | $479M | $508M | $636M | $316M | $475M | $149M | $170M | $104M | $45M | |
| PP&E (Net) | $131M | $109M | $114M | $105M | $101M | $59M | $9M | $3M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $180M | $145M | $142M | $122M | $110M | $65M | $13M | $7M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $49M | $36M | $28M | $17M | $9M | $6M | $4M | $4M | $3M | $2M | $1M | $104.0K | |
| Intangibles | $279M | $282M | $229M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $369.0K | $270.0K | $189.0K | $2M | $13M | $3M | $3M | $4M | $0 | · | · | |
| Total Assets | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Accounts Payable | $22M | $28M | $33M | $27M | $27M | $14M | $16M | $3M | $1M | $863.0K | $958.0K | $1M | |
| Accrued Liabilities | $111M | $82M | $69M | $52M | $57M | $35M | $16M | $12M | $8M | $4M | $672.0K | $328.0K | |
| Short-term Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $138M | $122M | $110M | $91M | $89M | $55M | $39M | $14M | $10M | $5M | $2M | $2M | |
| Capital Leases | $44M | $44M | $67M | $72M | $65M | $45M | $4M | $0 | · | · | · | · | |
| Deferred Tax | $32M | $32M | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $12M | $2M | $230.0K | · | · | · | · | |
| Total Liabilities | $215M | $200M | $196M | $164M | $156M | $112M | $46M | $15M | $10M | · | · | · | |
| Total Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $3.46B | $3.10B | $2.59B | $2.07B | $1.79B | $1.49B | $869M | $839M | $395M | $324M | $208M | $121M | |
| Retained Earnings | $-2.78B | $-2.38B | $-2.01B | $-1.57B | $-1.17B | $-830M | $-571M | $-373M | $-249M | $-157M | $-104M | $-77M | |
| AOCI | $16M | $-1M | $3M | $-902.0K | $-601.0K | $19.0K | $220.0K | $-42.0K | $0 | $29.0K | $48.0K | $0 | |
| Stockholders' Equity | $699M | $710M | $585M | $500M | $622M | $656M | $299M | $466M | $145M | $167M | $104M | $45M | |
| Liabilities + Equity | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Shares Outstanding | 411,938,061 | 305,252,194 | 256,135,715 | 187,812,072 | 157,004,742 | 147,874,917 | 126,411,808 | 123,415,576 | 73,164,914 | 62,248,074 | 48,547,720 | 33,750,188 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $11M | $12M | $9M | $3M | $1M | $1M | $956.0K | $952.0K | $978.0K | $999.0K | $88.0K | |
| Stock-based Comp | $62M | $110M | $63M | $84M | $70M | $41M | $24M | $20M | $12M | $19M | $9M | $4M | |
| Deferred Tax | $-2M | $-3M | $-3M | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $23M | $26M | $10M | $0 | · | · | · | · | · | · | · | · | |
| Restructuring | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $16M | $-100M | $12M | $10M | $41M | $12M | $13M | · | · | · | · | · | |
| Operating Cash Flow | $-302M | $-353M | $-362M | $-293M | $-228M | $-205M | $-159M | $-101M | $-79M | $-33M | $-18M | $-9M | |
| CapEx | $34M | $11M | $22M | $20M | $38M | $47M | $7M | $1M | $1M | $2M | $1M | $2M | |
| Investing Cash Flow | $47M | $-96M | $-155M | $256M | $132.0K | $-318M | $90M | $-386M | $59M | $9M | $-71M | · | |
| Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Stock Issued | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | $32M | |
| Net Stock Activity | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | · | |
| Financing Cash Flow | $301M | $391M | $463M | $190M | $239M | $576M | $6M | $424M | $59M | $97M | $78M | · | |
| Net Change in Cash | $47M | $-59M | $-57M | $154M | $11M | · | · | $-63M | $39M | $73M | $-11M | $25M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-336M | $-364M | $-384M | $-313M | $-266M | $-252M | $-166M | $-102M | $-80M | $-34M | $-20M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -153.1% | -240.9% | -38735.0% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -148.4% | -226.8% | -37345.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -149.2% | -228.6% | -37638.0% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -148.2% | -233.6% | -37762.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -42.9% | -44.0% | -61.5% | -54.9% | -44.3% | -46.6% | -47.9% | -38.9% | -56.3% | -38.1% | -36.4% | · | |
| ROE | -56.0% | -50.2% | -70.6% | -88.6% | -51.9% | -37.9% | -60.4% | -34.3% | -58.9% | -39.0% | -37.2% | · | |
| ROIC | -57.4% | -55.2% | -78.2% | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 | 11.6 | 8.1 | 33.0 | 15.1 | 34.1 | 63.8 | · | |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 | 11.5 | 7.9 | 32.5 | 14.7 | 33.5 | 51.4 | · | |
| Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.0 | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 3.4 | 4.0 | 2.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 4.7 | 15.7 | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.70 | $2.33 | $2.28 | $2.66 | $3.96 | $4.47 | $2.37 | $3.78 | $1.99 | $2.68 | $2.14 | · | |
| Revenue / Share | $737.39 | $566.00 | $5.06 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-846.26 | $-1217.68 | $-1538.80 | $-1838.24 | $-1485.87 | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.38 | $0.45 | $1.23 | $0.50 | $0.46 | $0.11 | $0.67 | $1.99 | $1.71 | $0.28 | · | |
| EPS (TTM) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.6% | 13699.0% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $264M | $164M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| Market Cap | $1.12B | $2.26B | $2.08B | $1.20B | $3.00B | $6.81B | $3.50B | $1.09B | $585M | $433M | $375M | · | |
| Enterprise Value | $829M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -5.8 | -4.3 | -2.6 | -8.6 | -24.7 | -17.4 | · | · | · | · | · | |
| P/S | 4.3 | 13.8 | 1751.4 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.6 | 3.2 | 3.6 | 2.4 | 4.8 | 10.4 | 11.7 | 2.3 | 4.0 | 2.6 | 3.6 | · | |
| P / Tangible Book | 2.7 | 5.3 | 5.9 | 2.4 | 4.8 | 10.4 | · | · | · | · | · | · | |
| P / Cash Flow | -3.7 | -6.4 | -5.8 | -4.1 | -13.1 | -33.2 | -22.0 | -10.8 | -7.4 | -13.2 | -20.4 | · | |
| P / FCF | -3.3 | -6.2 | -5.4 | -3.8 | -11.3 | -27.1 | -21.1 | -10.7 | -7.3 | -12.7 | -19.2 | · | |
| EV / EBITDA | -2.1 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -2.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.9% | -17.3% | -23.2% | -39.0% | -11.7% | -4.0% | -5.7% | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99M | $71M | $87M | $67M | $60M | $49M | $74M | $59M | $31M | $715.0K | $482.0K | $469.0K | $238.0K | · | · | · | |
| Cost of Revenue | $44M | $42M | $28M | $38M | $49M | $43M | $23M | $32M | $31M | $7M | $-5M | $4M | $2M | · | · | · | |
| R&D Expense | $59M | $62M | $69M | $75M | $78M | $76M | $67M | $67M | $62M | $80M | $77M | $88M | $86M | $83M | $73M | $73M | |
| SG&A Expense | $39M | $39M | $36M | $35M | $38M | $44M | $42M | $39M | $40M | $31M | $29M | $27M | $22M | $28M | $28M | $26M | |
| Operating Expenses | $151M | $152M | $160M | $162M | $174M | $171M | $160M | $148M | $133M | $118M | $122M | $119M | $110M | $111M | $100M | $100M | |
| Operating Income | $-52M | $-81M | $-73M | $-95M | $-114M | $-121M | $-87M | $-89M | $-102M | $-118M | $-121M | $-118M | $-110M | $-111M | $-100M | $-100M | |
| Interest Income | $3M | $1M | $2M | $1M | $4M | $3M | $10M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $777.0K | $385.0K | |
| Pretax Income | $-49M | $-80M | $-72M | $-94M | $-110M | $-118M | $-77M | $-85M | $-99M | $-114M | $-118M | $-115M | $-107M | $-107M | $-100M | $-99M | |
| Income Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | · | |
| Net Income | $-47M | $-79M | $-72M | $-91M | $-112M | $-116M | $-79M | $-84M | $-97M | $-113M | $-116M | $-114M | $-107M | $-107M | $-100M | $-99M | |
| EPS (Basic) | $-0.11 | $-0.19 | $-0.15 | $-0.25 | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.63 | $-0.63 | |
| EPS (Diluted) | $-0.11 | $-0.19 | · | · | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.63 | $-0.63 | |
| Shares (Basic) | 450,189 | 418,511 | · | 364,037 | 334,511 | 322,868 | · | 303,269 | 284,817 | 266,220 | · | 245,817 | 224,481 | 213,694,000 | 157,817,000 | 157,274,000 | |
| Shares (Diluted) | 450,189 | 418,511 | · | · | 334,511 | 322,868 | · | 303,269 | 284,817 | 266,220 | · | 245,817 | 224,481 | 213,694,000 | 157,817,000 | 157,274,000 | |
| EBITDA | $-52M | $-78M | · | $-95M | $-110M | $-118M | · | $-86M | $-99M | $-115M | · | $-115M | $-107M | $-108M | $-100M | $-100M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $197M | $163M | $158M | $132M | $172M | $116M | $164M | $229M | $134M | $115M | $268M | $230M | $543M | $118M | $108M | |
| Short-term Investments | $187M | $117M | $134M | $143M | $169M | $188M | $208M | $233M | $184M | $222M | · | $94M | $21M | $83M | $242M | $316M | |
| Receivables | $102M | $82M | $82M | $67M | $60M | $71M | $69M | $56M | $32M | $234.0K | · | · | $33.0K | · | · | · | |
| Inventory | $56M | $58M | $52M | $52M | $50M | $66M | $52M | $39M | $28M | $18M | · | $9M | $10M | · | · | · | |
| Prepaid Expense | $9M | $13M | $12M | $10M | $12M | $16M | $12M | $7M | $10M | $11M | · | $12M | $14M | $11M | $10M | $7M | |
| Current Assets | $464M | $467M | $443M | $429M | $422M | $513M | $457M | $499M | $482M | $386M | · | $383M | $275M | $638M | $370M | $432M | |
| PP&E (Net) | $131M | $131M | $131M | $127M | $122M | $112M | $109M | $113M | $111M | $112M | · | $113M | $113M | $110M | $101M | $101M | |
| PP&E (Gross) | $188M | $184M | $180M | $172M | $165M | $150M | $145M | $149M | $145M | $143M | · | $138M | $135M | $129M | $115M | $113M | |
| Accum. Depreciation | $56M | $52M | $49M | $45M | $42M | $39M | $36M | $37M | $34M | $31M | · | $25M | $22M | $19M | $14M | $11M | |
| Intangibles | $264M | $269M | $279M | $285M | $296M | $285M | $282M | $307M | $295M | $294M | · | $224M | $236M | · | · | · | |
| Other Non-current Assets | $6M | $8M | $8M | $9M | $10M | $426.0K | $369.0K | $280.0K | $327.0K | $259.0K | · | $282.0K | $294.0K | $202.0K | $596.0K | $856.0K | |
| Total Assets | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | $546M | $611M | |
| Accounts Payable | $26M | $37M | $22M | $31M | $32M | $28M | $28M | $32M | $20M | $26M | · | $19M | $31M | $32M | $24M | $20M | |
| Accrued Liabilities | $78M | $88M | $111M | $87M | $89M | $85M | $82M | $75M | $62M | $46M | · | $61M | $47M | $43M | $48M | $38M | |
| Short-term Debt | · | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $107M | $129M | $138M | $126M | $129M | $123M | $122M | $118M | $94M | $83M | · | $91M | $89M | $87M | $79M | $64M | |
| Capital Leases | $43M | $44M | $44M | $45M | $45M | $44M | $44M | $66M | $69M | $72M | · | $68M | $69M | $70M | $72M | $73M | |
| Deferred Tax | $29M | $31M | $32M | $32M | $35M | $32M | $32M | $32M | $32M | $33M | · | $18M | $20M | · | · | · | |
| Total Liabilities | $179M | $204M | $215M | $203M | $209M | $199M | $200M | $218M | $196M | $190M | · | $178M | $179M | $158M | $152M | $138M | |
| Total Debt | · | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $18.0K | $17.0K | $16.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $12.0K | · | $11.0K | $9.0K | $9.0K | $7.0K | $7.0K | |
| Paid-in Capital | $3.62B | $3.56B | $3.46B | $3.39B | $3.29B | $3.26B | $3.10B | $3.06B | $2.99B | $2.81B | · | $2.58B | $2.36B | $2.34B | $1.86B | $1.84B | |
| Retained Earnings | $-2.90B | $-2.85B | $-2.78B | $-2.70B | $-2.61B | $-2.50B | $-2.38B | $-2.31B | $-2.22B | $-2.13B | · | $-1.90B | $-1.78B | $-1.68B | $-1.46B | $-1.36B | |
| AOCI | $13M | $13M | $16M | $16M | $21M | $6M | $-1M | $16M | $526.0K | $116.0K | · | $-9M | $325.0K | $-126.0K | $-2M | $-3M | |
| Stockholders' Equity | $736M | $722M | $699M | $702M | $698M | $768M | $710M | $773M | $769M | $680M | $585M | $674M | $579M | $667M | $394M | $473M | |
| Liabilities + Equity | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | $546M | $611M | |
| Shares Outstanding | 452,971,016 | 438,106,537 | 411,938,061 | 385,461,728 | 341,919,364 | 333,934,387 | 305,252,194 | 304,620,470 | 297,305,999 | 279,756,339 | · | 255,833,679 | 224,688,434 | 224,358,979 | 157,840,581 | 157,800,581 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Stock-based Comp | $12M | $11M | $12M | $12M | $15M | $23M | $31M | $31M | $30M | $17M | $14M | $16M | $17M | $16M | $20M | $22M | |
| Deferred Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | $0 | · | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $11M | $6M | $6M | $5M | $4M | $4M | $2M | $0 | $0 | $0 | |
| Restructuring | · | · | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-6M | · | · | · | $-11M | · | · | · | $-28M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $-61M | $-72M | $-53M | $-79M | $-67M | $-104M | $-73M | $-59M | $-98M | $-122M | $-84M | $-84M | $-94M | $-100M | $-64M | $-78M | |
| CapEx | $5M | $7M | $9M | $11M | $7M | $6M | $4M | $2M | $442.0K | $4M | $4M | $4M | $10M | $6M | $1M | $5M | |
| Investing Cash Flow | $-74M | $11M | $775.0K | $17M | $14M | $16M | $24M | $-49M | $40M | $-112M | $-73M | $-79M | $-157M | $153M | $74M | $96M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Stock Issued | $50M | $99M | $56M | $89M | $13M | $149M | $0 | $48M | $152M | $198M | $1.0K | $203M | $0 | $260M | $0 | $0 | |
| Net Stock Activity | · | $99M | · | · | · | $149M | · | · | · | $198M | · | · | · | $260M | · | · | |
| Financing Cash Flow | $49M | $94M | $56M | $88M | $13M | $143M | $2M | $42M | $153M | $194M | $962.0K | $203M | $1M | $258M | $225.0K | $-2M | |
| Net Change in Cash | $-86M | $33M | $5M | $26M | $-40M | $56M | $-48M | $-65M | $94M | $-41M | $-153M | $38M | $-253M | $312M | $10M | · | |
| Free Cash Flow | · | $-79M | · | · | · | $-110M | · | · | · | $-126M | · | · | · | $-105M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -52.3% | -113.5% | · | -140.7% | -189.8% | -245.8% | · | -152.1% | -327.6% | -16464.6% | · | -25236.9% | -46254.6% | · | · | · | |
| Net Margin | -47.6% | -110.7% | · | -135.3% | -186.2% | -235.5% | · | -142.7% | -312.2% | -15800.8% | · | -24255.9% | -44759.7% | · | · | · | |
| Pretax Margin | -49.0% | -111.6% | · | -138.8% | -182.9% | -239.2% | · | -145.3% | -316.8% | -15997.8% | · | -24520.9% | -44960.1% | · | · | · | |
| EBITDA Margin | -52.3% | -109.5% | · | -140.7% | -184.1% | -240.1% | · | -147.0% | -318.0% | -16048.1% | · | -24618.5% | -45036.1% | · | · | · | |
| ROA | -5.2% | -8.3% | · | -9.6% | -11.9% | -12.7% | · | -9.1% | -11.3% | -13.3% | · | -16.3% | -15.6% | -14.1% | -14.5% | -13.6% | |
| ROE | -6.6% | -10.6% | · | -12.4% | -15.2% | -16.1% | · | -11.5% | -14.4% | -16.8% | · | -21.3% | -20.3% | -17.6% | -18.2% | -16.3% | |
| ROIC | -6.9% | -11.1% | · | -13.2% | -16.6% | -15.5% | · | -11.3% | -13.1% | -17.1% | · | -17.4% | -18.9% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 3.6 | · | 3.4 | 3.3 | 4.2 | · | 4.2 | 5.2 | 4.6 | · | 4.2 | 3.1 | 7.3 | 4.7 | 6.7 | |
| Quick Ratio | 3.7 | 3.1 | · | 2.9 | 2.8 | 3.5 | · | 3.8 | 4.7 | 4.3 | · | 4.0 | 2.8 | 7.2 | 4.5 | 6.6 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.7 | · | 0.9 | 1.5 | 1.2 | · | 1.7 | 1.7 | 0.8 | · | 0.9 | 0.4 | · | · | · | |
| Receivables Turnover | 1.2 | 0.9 | · | 1.1 | 1.3 | 1.4 | · | 2.1 | 2.0 | 6.1 | · | · | 14.4 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.62 | $1.65 | · | $1.82 | $2.04 | $2.30 | · | $2.54 | $2.58 | $2.43 | · | $2.63 | $2.58 | $2.97 | $2.49 | $3.00 | |
| Revenue / Share | $220.60 | $170.68 | · | · | $179.22 | $152.77 | · | $193.08 | $109.21 | $0.00 | · | $0.00 | $0.00 | · | · | · | |
| Cash Flow / Share | · | $-172.22 | · | · | · | $-321.17 | · | · | · | $-0.46 | · | · | · | $-0.47 | · | · | |
| Cash / Share | $0.24 | $0.45 | · | $0.41 | $0.39 | $0.51 | · | $0.54 | $0.77 | $0.48 | · | $1.05 | $1.02 | $2.42 | $0.75 | $0.68 | |
| EPS (TTM) | · | · | · | $-1.21 | $-1.21 | $-1.22 | · | $-1.50 | $-1.68 | $-1.81 | · | $-2.08 | $-2.25 | $-2.41 | $-2.48 | $-2.40 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $325M | $286M | · | $250M | $242M | $213M | · | $91M | $33M | $2M | · | · | · | $0 | $0 | $0 | |
| Net Income TTM | $-290M | $-354M | · | $-398M | $-390M | $-375M | · | $-410M | $-440M | $-450M | · | $-433M | $-419M | $-412M | $-390M | $-376M | |
| Market Cap | $1.88B | $1.54B | · | $836M | $588M | $1.11B | · | $2.86B | $2.38B | $4.15B | · | $1.16B | $1.58B | $1.37B | $1.51B | $1.74B | |
| Enterprise Value | · | $1.23B | · | $537M | $288M | $753M | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | · | · | -1.8 | -1.4 | -2.7 | · | -6.3 | -4.8 | -8.2 | · | -2.2 | -3.1 | -2.5 | -3.9 | -4.6 | |
| P/S | 5.8 | 5.4 | · | 3.3 | 2.4 | 5.2 | · | 31.5 | 72.8 | 2177.5 | · | · | · | · | · | · | |
| P/B | 2.6 | 2.1 | · | 1.2 | 0.8 | 1.4 | · | 3.7 | 3.1 | 6.1 | · | 1.7 | 2.7 | 2.1 | 3.8 | 3.7 | |
| P / Tangible Book | 4.0 | 3.4 | · | 2.0 | 1.5 | 2.3 | · | 6.1 | 5.0 | 10.7 | · | 2.6 | 4.6 | 2.1 | 3.8 | 3.7 | |
| P / Cash Flow | · | -21.3 | · | · | · | -10.7 | · | · | · | -33.9 | · | · | · | -13.7 | · | · | |
| EV / Revenue | · | 4.3 | · | 2.1 | 1.2 | 3.5 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -55.8% | -70.3% | -36.6% | · | -16.0% | -20.9% | -12.2% | · | -45.7% | -32.0% | -39.4% | -25.9% | -21.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $264M | $164M | $1M | · | · |
| Operating Margin % | -153.1% | -240.9% | -38735.0% | · | · |
| Net Income | $-391M | $-372M | $-444M | $-396M | $-342M |
| Diluted EPS | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | · | · | · | · |
| Current Ratio | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-336M | $-364M | $-384M | $-313M | $-266M |
Institutional owners (13F) 316 filers · $1.3B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
316
Value held
$1.3B
New positions
44
Exited positions
35
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 44 (-27 vs prior Q) | 35 (+1 vs prior Q) | 134 (+11 vs prior Q) | 63 (+1 vs prior Q) | +19.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $153,743,956 | 36,957,681 | 12.11% | Shares |
| MHR FUND MANAGEMENT LLC | $120,503,148 | 28,967,103 | 9.49% | Shares |
| STATE STREET CORP | $101,829,595 | 24,478,268 | 8.02% | Shares |
| TWO SIGMA INVESTMENTS, LP | $79,084,500 | 19,010,697 | 6.23% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $75,729,672 | 18,204,248 | 5.96% | Shares |
| VANGUARD GROUP INC | $74,275,326 | 27,207,079 | 5.85% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $59,858,236 | 14,388,999 | 4.71% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $42,958,080 | 10,324,826 | 3.38% | Shares |
| MILLENNIUM MANAGEMENT LLC | $35,467,823 | 8,525,919 | 2.79% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $26,877,382 | 6,460,449 | 2.12% | Shares |
| Palo Alto Investors LP | $22,032,229 | 5,296,209 | 1.73% | Shares |
| GOLDMAN SACHS GROUP INC | $21,200,749 | 5,096,334 | 1.67% | Shares |
| Nuveen, LLC | $20,787,985 | 4,997,112 | 1.64% | Shares |
| BANK OF AMERICA CORP /DE/ | $20,773,309 | 4,993,584 | 1.64% | Shares |
| MORGAN STANLEY | $20,743,678 | 4,986,461 | 1.63% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $18,865,933 | 4,535,080 | 1.49% | Shares |
| JANE STREET GROUP, LLC | $18,278,428 | 4,393,853 | 1.44% | Shares |
| NORTHERN TRUST CORP | $17,281,471 | 4,154,200 | 1.36% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $16,097,468 | 3,869,584 | 1.27% | Shares |
| WELLS FARGO & COMPANY/MN | $13,505,594 | 3,246,537 | 1.06% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13,393,769 | 3,219,656 | 1.05% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,097,216 | 2,667,600 | 0.87% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,052,038 | 2,656,740 | 0.87% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $10,578,372 | 2,542,878 | 0.83% | Shares |
| JPMORGAN CHASE & CO | $10,237,104 | 2,431,616 | 0.81% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,953,632 | 2,392,700 | 0.78% | Put option |
| D. E. Shaw & Co., Inc. | $8,915,437 | 2,143,134 | 0.70% | Shares |
| CITADEL ADVISORS LLC | $8,756,758 | 2,104,990 | 0.69% | Shares |
| Long Focus Capital Management, LLC | $8,736,000 | 2,100,000 | 0.69% | Shares |
| Orion Investment Co | $8,624,520 | 2,073,202 | 0.68% | Shares |
| TWO SIGMA ADVISERS, LP | $8,230,950 | 3,015,000 | 0.65% | Shares |
| Xcelsior Advisor Partners LLC | $7,421,124 | 1,783,924 | 0.58% | Shares |
| Rhenman & Partners Asset Management AB | $7,094,160 | 1,705,327 | 0.56% | Shares |
| Knott David M Jr | $6,656,000 | 1,600,000 | 0.52% | Shares |
| RICE HALL JAMES & ASSOCIATES, LLC | $6,405,734 | 1,539,840 | 0.50% | Shares |
| B Group, Inc. | $6,240,000 | 1,500,000 | 0.49% | Shares |
| Invenomic Capital Management LP | $6,167,595 | 1,482,595 | 0.49% | Shares |
| Woodline Partners LP | $5,671,020 | 1,363,226 | 0.45% | Shares |
| FMR LLC | $5,638,373 | 1,355,378 | 0.44% | Shares |
| UBS Group AG | $5,373,323 | 1,291,664 | 0.42% | Shares |
| Invesco Ltd. | $5,346,332 | 1,285,176 | 0.42% | Shares |
| Bank of New York Mellon Corp | $4,834,325 | 1,162,097 | 0.38% | Shares |
| Mirador Capital Partners LP | $4,493,998 | 1,080,288 | 0.35% | Shares |
| Susquehanna Portfolio Strategies, LLC | $4,391,217 | 1,055,581 | 0.35% | Shares |
| SECTOR GAMMA AS | $4,028,819 | 968,466 | 0.32% | Shares |
| CITIGROUP INC | $3,669,669 | 882,132 | 0.29% | Shares |
| DEUTSCHE BANK AG\ | $3,556,688 | 854,973 | 0.28% | Shares |
| Jump Financial, LLC | $3,435,757 | 825,903 | 0.27% | Shares |
| CITADEL ADVISORS LLC | $3,385,824 | 813,900 | 0.27% | Call option |
| JANE STREET GROUP, LLC | $3,037,216 | 730,100 | 0.24% | Call option |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Quogue Capital LLC, Wayne P. Rothbaum ×5 filings | March 19, 2024 | · | Initial filing | · | SEC |
| Undisclosed reporting person | Feb. 11, 2015 | · | Initial filing | · | SEC |
| Bristol Investment Fund, Ltd., Bristol Capital, LLC ×4 filings | Feb. 20, 2014 | · | Initial filing | · | SEC |
| Robert T. Brooke ×2 filings | May 12, 2011 | · | Initial filing | · | SEC |
| Hamilton Atlantic | Nov. 5, 2010 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person | March 29, 2010 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 40 insiders · 11 officers · 16 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Frederick G Vogt | Interim CEO & General Counsel | Sept. 8, 2026 M | 595,447 | 0 | 0 | $0 |
| Maria Fardis | President and CEO | Jan. 4, 2021 A | 298,786 | 0 | 0 | $0 |
| Paul Kessler | Chair,CEO, Pres., Pr.Acctg | July 24, 2013 A | 15,693,215 | 0 | 0 | $0 |
| Tony Cataldo | CEO, President | May 6, 2011 A | 3,000,000 | 0 | 0 | $0 |
| Jean-Marc Bellemin | Chief Financial Officer | June 2, 2025 M | 60,529 | 0 | 0 | $0 |
| Timothy E Morris | Chief Financial Officer | March 4, 2019 A | · | 0 | 0 | $0 |
| Igor Bilinsky | Chief Operating Officer | Sept. 8, 2026 M | 142,074 | 0 | 0 | $0 |
| Noah Berkowitz | Chief Medical Officer | Sept. 30, 2026 A | · | 0 | 0 | $0 |
| Raj K. Puri | Chief Regulatory Officer | Sept. 8, 2026 M | 256,364 | 0 | 0 | $0 |
| Finckenstein Friedrich Graf | Chief Medical Officer | June 5, 2026 M | 140,111 | 0 | 0 | $0 |
| Michael Swartzburg | Vice President, Finance (PAO) | Jan. 4, 2021 A | · | 0 | 0 | $0 |
| Iain D. Dukes | Director | June 16, 2026 A | 54,000 | 0 | 0 | $0 |
| Athena Countouriotis | Director | June 16, 2026 A | · | 0 | 0 | $0 |
| Ryan D Maynard | Director | June 16, 2026 A | 7,500 | 0 | 0 | $0 |
| Michael Weiser | Director | June 16, 2026 A | 112,632 | 0 | 0 | $0 |
| Wendy L Yarno | Director | June 13, 2025 A | · | 0 | 0 | $0 |
| Wayne P. Rothbaum | Director | March 1, 2024 A | 28,067,333 | 0 | 0 | $0 |
| Merrill A Mcpeak | Director | March 1, 2024 A | 320,150 | 0 | 0 | $0 |
| Wendy L Dixon | Director | June 10, 2022 A | · | 0 | 0 | $0 |
| David J Voyticky | Director | July 24, 2013 A | 13,353,215 | 0 | 0 | $0 |
| Ayer Capital Management, LP | Director | May 22, 2013 C | 560,401,150 | 0 | 0 | $0 |
| Martin Schroeder | Director | Aug. 22, 2011 P | 1,000,000 | 0 | 0 | $0 |
| Mark J Ahn | Director | May 26, 2010 A | · | 0 | 0 | $0 |
| Bristol Investment Fund, Ltd. | 10% owner | Nov. 6, 2014 S | 3,867,863 | 0 | 0 | $0 |
| Hamilton Atlantic | 10% owner | March 31, 2010 J | 0 | 0 | 0 | $0 |
| Daniel Gordon Kirby | · | Aug. 10, 2026 M | 154,511 | 0 | 0 | $0 |
| Corleen M. Roche | · | Aug. 6, 2026 M | 28,757 | 0 | 0 | $0 |
| Jay Venkatesan | · | June 1, 2017 A | · | 0 | 0 | $0 |
| Sanford Hillsberg | · | June 1, 2017 A | 100,000 | 0 | 0 | $0 |
| Gregory T Schiffman | · | Nov. 14, 2016 A | · | 0 | 0 | $0 |
| Molly Henderson | · | June 10, 2016 A | · | 0 | 0 | $0 |
| Michael Lotze | · | March 28, 2016 A | · | 0 | 0 | $0 |
| James G. Bender | · | March 11, 2016 A | 88,726 | 0 | 0 | $0 |
| Elma Hawkins | · | March 11, 2016 A | 176,567 | 0 | 0 | $0 |
| Steven A. Fischkoff | · | Feb. 4, 2016 A | · | 0 | 0 | $0 |
| Laszlo Radvanyi | · | Dec. 5, 2014 A | 180,000 | 0 | 0 | $0 |
| Michael D Handelman | · | Dec. 5, 2014 A | · | 0 | 0 | $0 |
| Manish Singh | · | Dec. 30, 2013 A | 2,546,000 | 0 | 0 | $0 |
| Richard Mckilligan | · | March 29, 2011 J | 1,220,016 | 0 | 0 | $0 |
| Robert T. Brooke | · | March 25, 2011 J | 4,440,008 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 35 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IDNA · iShares Trust | 3.07% | 963,108 SH | Sept. 11, 2026 | Daily |
| BBP · ETFis Series Trust I | 1.37% | 332,635 NS | July 31, 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.94% | 14,671 SH | Oct. 1, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.47% | 858,583 SH | Oct. 1, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.44% | 32,023 SH | Oct. 1, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.41% | 492,493 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.23% | 2,961,520 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.11% | 6,729 NS | July 31, 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.11% | 346,628 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.11% | 10,163,644 SH | Sept. 11, 2026 | Daily |
| TECB · iShares Trust | 0.06% | 38,134 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.05% | 190,525 NS | July 31, 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.05% | 261,797 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.05% | 2,290,247 SH | Aug. 19, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.03% | 45,144 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.03% | 21,763 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.03% | 962,767 NS | July 31, 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 166,388 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 4,303,944 SH | Aug. 19, 2026 | Daily |
| VBR · VANGUARD INDEX FUNDS | 0.02% | 3,089,380 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.02% | 1,053,780 SH | Aug. 19, 2026 | Daily |
| TILT · FlexShares Trust | 0.01% | 74,822 NS | July 31, 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.01% | 4,849,607 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.01% | 1,049,483 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 63,899 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 28,098 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 146,278 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 510,942 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 106,978 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 125,583 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 13,489,795 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 32,806 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 3,730,642 SH | Sept. 11, 2026 | Daily |
| ISCB · iShares Trust | · | 15,580 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 77,914 SH | Sept. 11, 2026 | Daily |
IOVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 15 analysts
BUY
Median target
$13.00
-8.5%
3 20.0%
Strong Buy
9 60.0%
Buy
3 20.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-30Mean target $12.40 -12.8%
Now
Current price $14.21
Low$6.00
Mean$12.40
High$20.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| IONS | $12.92B | -33.2 | · | · | -68.1% | · |
| IMVT | $5.07B | -9.0 | 229.2% | · | -73.7% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
Latest News Recent headlines mentioning this company
Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here’s What Comes Next
Yahoo Finance · 1 month, 3 weeks ago
Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small-Cap Stocks to Buy Now?
Yahoo Finance · 3 months, 3 weeks ago
Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
Yahoo Finance · 4 months, 2 weeks ago
Iovance Biotherapeutics Q1 Earnings Call Highlights
Yahoo Finance · 4 months, 3 weeks ago
Analyst Sentiment Remains Strong on Iovance Biotherapeutics (IOVA) Amid U.S. Rollout of Melanoma Drug, Amtagvi
Yahoo Finance · 6 months, 1 week ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026